| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Beneficial therapeutic effects with different particulate structures of murine polyomavirus VP1-coat protein carrying self or non-self CD8 T cell epitopes against murine melanoma
|
Brinkman, Marc
|
|
2005
|
54 |
6 |
p. 611-622
|
artikel
|
| 2 |
Binding parameters of antibodies: pseudo-affinity and other misconceptions
|
Mattes, M. Jules.
|
|
2004
|
54 |
6 |
p. 513-516
|
artikel
|
| 3 |
Clinical trials of antitumor vaccination with an autologous tumor cell vaccine modified by virus infection: improvement of patient survival based on improved antitumor immune memory
|
Schirrmacher, Volker
|
|
2004
|
54 |
6 |
p. 587-598
|
artikel
|
| 4 |
Immune prevention of mammary carcinogenesis in HER-2/neu transgenic mice: a microarray scenario
|
Astolfi, Annalisa
|
|
2005
|
54 |
6 |
p. 599-610
|
artikel
|
| 5 |
Immune prevention of mammary carcinogenesis in HER-2/neu transgenic mice: a microarray scenario
|
Astolfi, Annalisa
|
|
|
54 |
6 |
p. 599-610
|
artikel
|
| 6 |
Lack of effective T-lymphocyte response to the PAX3/FKHR translocation area in alveolar rhabdomyosarcoma
|
Rodeberg, David A.
|
|
2004
|
54 |
6 |
p. 526-534
|
artikel
|
| 7 |
New developments in dendritic cell–based vaccinations: RNA translated into clinics
|
Grünebach, Frank
|
|
2005
|
54 |
6 |
p. 517-525
|
artikel
|
| 8 |
Pharmacokinetics and in vitro and in vivo anti-tumor response of an interleukin-2-human serum albumin fusion protein in mice
|
Melder, Robert J.
|
|
2004
|
54 |
6 |
p. 535-547
|
artikel
|
| 9 |
Prevention of de novo prostate cancer by immunization with tumor-derived vaccines
|
Suckow, Mark A.
|
|
|
54 |
6 |
p. 571-576
|
artikel
|
| 10 |
Prevention of de novo prostate cancer by immunization with tumor-derived vaccines
|
Suckow, Mark A.
|
|
2005
|
54 |
6 |
p. 571-576
|
artikel
|
| 11 |
Secretomers as a new tool for the monitoring of CTL responses
|
Calmels, Bastien
|
|
2004
|
54 |
6 |
p. 548-556
|
artikel
|
| 12 |
T-cell receptor BV gene usage in colorectal carcinoma patients immunised with recombinant Ep-CAM protein or anti-idiotypic antibody
|
Mosolits, Szilvia
|
|
2004
|
54 |
6 |
p. 557-570
|
artikel
|
| 13 |
What is needed for effective antitumor immunotherapy? Lessons learned using Listeria monocytogenes as a live vector for HPV-associated tumors
|
Hussain, S. Farzana
|
|
2005
|
54 |
6 |
p. 577-586
|
artikel
|
Tijdschrift beschrijving